Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Koido, Shigeo ^a   Homma, Sadamu ^a   Takahara, Akitaka ^a   Namiki, Yoshihisa ^a   Komita, Hideo ^a   Nagasaki, Eijiro ^a   Ito, Masaki ^a   Nagatsuma, Keisuke ^a   Uchiyama, Kan ^a   Satoh, Kenichi ^a   Ohkusa, Toshifumi ^a   Gong, Jianlin ^b   Tajiri, Hisao ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CHROMIUM 51; CYTOKINE; T LYMPHOCYTE RECEPTOR; THYMIDINE; TUMOR ANTIGEN;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL FUSION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL MONITORING; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; PROTEIN MULTIMERIZATION; REVIEW; T LYMPHOCYTE; TUMOR; TUMOR CELL; ANIMAL; CYTOLOGY; IMMUNOLOGY; METHODOLOGY; NEOPLASM; PATHOLOGY;

MURINAE;

ANIMALS; CANCER VACCINES; CELL FUSION; DENDRITIC CELLS; HUMANS; MONITORING, IMMUNOLOGIC; NEOPLASMS; T-LYMPHOCYTES;

EID: 79959334978     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/910836     Document Type: Review

References (173)

1. Inaba K., Pack M., Inaba M., Sakuta H., Isdell F., Steinman R. M., High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes Journal of Experimental Medicine 1997 186 5 665 672 (Pubitemid 27381531)
2. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity Nature 1998 392 6673 245 252 (Pubitemid 28155090)
3. Steinman R. M., Swanson J., The endocytic activity of dendritic cells Journal of Experimental Medicine 1995 182 2 283 288
4. Steinman R. M., The dendritic cell system and its role in immunogenicity Annual Review of Immunology 1991 9 271 296
5. Barry M., Bleackley R. C., Cytotoxic T lymphocytes: all roads lead to death Nature Reviews Immunology 2002 2 6 401 409 (Pubitemid 37328747)
6. Wolchok J. D., Hoos A., O'Day S., Weber J. S., Hamid O., Lebb C., Maio M., Binder M., Bohnsack O., Nichol G., Humphrey R., Hodi F. S., Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria Clinical Cancer Research 2009 15 23 7412 7420
7. Banchereau J., Palucka A. K., Dendritic cells as therapeutic vaccines against cancer Nature Reviews Immunology 2005 5 4 296 306 (Pubitemid 40516155)
8. Inaba K., Witmer-Pack M., Inaba M., Hathcock K. S., Sakuta H., Azuma M., Yagita H., Okumura K., Linsley P. S., Ikehara S., Muramatsu S., Hodes R. J., Stemman R. M., The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro Journal of Experimental Medicine 1994 180 5 1849 1860 (Pubitemid 24328575)
9. Young J. W., Inaba K., Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity Journal of Experimental Medicine 1996 183 1 7 11 (Pubitemid 26028740)
10. Celluzzi C. M., Mayordomo J. I., Storkus W. J., Lotze M. T., Falo L. D. Jr., Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity Journal of Experimental Medicine 1996 183 1 283 287 (Pubitemid 26028768)
11. Nestle F. O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nature Medicine 1998 4 3 328 332 (Pubitemid 28144092)
12. Nair S. K., Hull S., Coleman D., Gilboa E., Lyerly H. K., Morse M. A., Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA International Journal of Cancer 1999 82 1 121 124 (Pubitemid 29266116)
13. Koido S., Kashiwaba M., Chen D., Gendler S., Kufe D., Gong J., Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA The Journal of Immunology 2000 165 10 5713 5719
14. Palucka A. K., Ueno H., Connolly J., Kerneis-Norvell F., Blanck J. P., Johnston D. A., Fay J., Banchereau J., Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8 + T-cell immunity Journal of Immunotherapy 2006 29 5 545 557 (Pubitemid 44395279)
15. Thurner B., Haendle I., Rder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., Von Den Driesch P., Brcker E. B., Steinman R. M., Enk A., Kmpgen E., Schuler G., Vaccination with Mage-3A1 peptide-pulsed nature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma Journal of Experimental Medicine 1999 190 11 1669 1678 (Pubitemid 30002348)
16. Mackensen A., Herbst B. Jr., Chen JI. L., Khler G., Noppen C., Herr W., Spagnoli G. C., Cerundolo V., Lindemann A., Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34 + hematopoietic progenitor cells International Journal of Cancer 2000 89 2 385 392 (Pubitemid 30187500)
17. Gong J., Chen D., Kashiwaba M., Kufe D., Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells Nature Medicine 1997 3 5 558 561 (Pubitemid 27198656)
18. Koido S., Hara E., Homma S., Fujise K., Gong J., Tajiri H., Dendritic/tumor fusion cell-based vaccination against cancer Archivum Immunologiae et Therapiae Experimentalis 2007 55 5 281 287
19. Gong J., Koido S., Calderwood S. K., Cell fusion: from hybridoma to dendritic cell-based vaccine Expert Review of Vaccines 2008 7 7 1055 1068
20. Koido S., Hara E., Homma S., Namiki Y., Ohkusa T., Gong J., Tajiri H., Cancer vaccine by fusions of dendritic and cancer cells Clinical and Developmental Immunology 2009 2009 13
21. Koido S., Homma S., Hara E., Namiki Y., Ohkusa T., Gong J., Tajiri H., Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells Journal of Biomedicine and Biotechnology 2010 2010 12
22. Celluzzi C. M., Falo L. D. Jr., Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection The Journal of Immunology 1998 160 7 3081 3085 (Pubitemid 28164693)
23. Shu S., Zheng R., Lee W. T., Cohen P. A., Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy Critical Reviews in Immunology 2007 27 5 463 483
24. Wang J., Saffold S., Cao X., Krauss J., Chen W., Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines The Journal of Immunology 1998 161 10 5516 5524 (Pubitemid 28519115)
25. Cao X., Zhang W., Wang J., Zhang M., Huang X., Hamada H., Chen W., Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells Immunology 1999 97 4 616 625 (Pubitemid 29356411)
26. Li J., Holmes L. M., Franek K. J., Burgin K. E., Wagner T. E., Wei Y., Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity Cancer Immunology, Immunotherapy 2001 50 9 456 462 (Pubitemid 33079341)
27. Phan V., Errington F., Cheong S. C., Kottke T., Gough M., Altmann S., Brandenburger A., Emery S., Strome S., Bateman A., Bonnotte B., Melcher A., Vile R., A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines Nature Medicine 2003 9 9 1215 1219 (Pubitemid 37173708)
28. Shimizu K., Kuriyama H., Kjaergaard J., Lee W., Tanaka H., Shu S., Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy Journal of Immunotherapy 2004 27 4 265 272 (Pubitemid 38833322)
29. Kuriyama H., Watanabe S., Kjaergaard J., Tamai H., Zheng R., Weinberg A. D., Hu H. M., Cohen P. A., Plautz G. E., Shu S., Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination Cellular Immunology 2006 243 1 30 40 (Pubitemid 46275615)
30. Ishida A., Tanaka H., Hiura T., Miura S., Watanabe S., Matsuyama K., Kuriyama H., Tanaka J., Kagamu H., Gejyo F., Yoshizawa H., Generation of anti-tumour effector T cells from nave T cells by stimulation with dendritic/tumour fusion cells Scandinavian Journal of Immunology 2007 66 5 546 554 (Pubitemid 47609703)
31. Ko E., Luo W., Peng L., Wang X., Ferrone S., Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity Cancer Research 2007 67 16 7875 7884 (Pubitemid 47281383)
32. alomskaite-Davalgiene S., epurniene K., atkauskas S., Venslauskas M. S., Mir L. M., Extent of cell electrofusion in vitro and in vivo is cell line dependent Anticancer Research 2009 29 8 3125 3130
33. Gong J., Apostolopoulos V., Chen D., Chen H., Koido S., Gendler S. J., Mckenzie I. F., Kufe D., Selection and characterization of MUC1-specific CD8 + T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells Immunology 2000 101 3 316 324
34. Koido S., Tanaka Y., Chen D., Kufe D., Gong J., The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic/tumor fusion cells in MUC1-transgenic mice The Journal of Immunology 2002 168 5 2111 2117 (Pubitemid 34171809)
35. Kao J. Y., Gong Y., Chen C. M., Zheng Q. D., Chen J. J., Tumor-derived TGF- reduces the efficacy of dendritic cell/tumor fusion vaccine The Journal of Immunology 2003 170 7 3806 3811 (Pubitemid 36359250)
36. Iinuma T., Homma S., Noda T., Kufe D., Ohno T., Toda G., Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine Journal of Clinical Investigation 2004 113 9 1307 1317 (Pubitemid 39069930)
37. Suzuki T., Fukuhara T., Tanaka M., Nakamura A., Akiyama K., Sakakibara T., Koinuma D., Kikuchi T., Tazawa R., Maemondo M., Hagiwara K., Saijo Y., Nukiwa T., Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells Clinical Cancer Research 2005 11 1 58 66 (Pubitemid 40075778)
38. Kao J. Y., Zhang M., Chen C. M., Chen J. J., Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer Immunology Letters 2005 101 2 154 159 (Pubitemid 41368073)
39. Xu F., Ye Y. J., Cui Z. R., Wang S., Allogeneic dendritomas induce anti-tumour immunity against metastatic colon cancer Scandinavian Journal of Immunology 2005 61 4 364 369 (Pubitemid 40637842)
40. Yasuda T., Kamigaki T., Kawasaki K., Nakamura T., Yamamoto M., Kanemitsu K., Takase S., Kuroda D., Kim Y., Ajiki T., Kuroda Y., Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma Cancer Immunology, Immunotherapy 2007 56 7 1025 1036 (Pubitemid 46675296)
41. Cho E. I., Tan C., Koski G. K., Cohen P. A., Shu S., Lee W. T., Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines Head and Neck 2010 32 6 700 707
42. Gong J., Chen D., Kashiwaba M., Li Y., Chen L., Takeuchi H., Ou H., Rowse G. J., Gendler S. J., Kufe D., Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6279 6283 (Pubitemid 28249003)
43. Lindner M., Schirrmacher V., Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols European Journal of Clinical Investigation 2002 32 3 207 217 (Pubitemid 36216606)
44. Xia J., Tanaka Y., Koido S., Liu C., Mukherjee P., Gendler S. J., Gong J., Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells The Journal of Immunology 2003 170 4 1980 1986 (Pubitemid 36197418)
45. Chen D., Xia J., Tanaka Y., Chen H., Koido S., Wernet O., Mukherjee P., Gendler S. J., Kufe D., Gong J., Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells Immunology 2003 109 2 300 307 (Pubitemid 36683622)
46. Tamai H., Watanabe S., Zheng R., Deguchi K., Cohen P. A., Koski G. K., Shu S., Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells Clinical Immunology 2008 127 1 66 77
47. Zhang M., Berndt B. E., Chen J. J., Kao J. Y., Expression of a soluble TGF- receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy The Journal of Immunology 2008 181 5 3690 3697
48. Guo G. H., Chen S. Z., Yu J., Zhang J., Luo L. L., Xie L. H., Su Z. J., Dong H. M., Xu H., Wu L. B., In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency World Journal of Gastroenterology 2008 14 8 1167 1174 (Pubitemid 351356323)
49. Ziske C., Etzrodt P. E., Eliu A. S., Gorschlter M., Strehl J., Flieger D., Messmer D., Schmitz V., Gonzalez-Carmona M. A., Sievers E., Brossart P., Sauerbruch T., Schmidt-Wolf I. G. H., Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids Pancreas 2009 38 7 758 765
50. Yamamoto M., Kamigaki T., Yamashita K., Hori Y., Hasegawa H., Kuroda D., Moriyama H., Nagata M., Ku Y., Kuroda Y., Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer Oncology Reports 2009 22 2 337 343
51. Homma S., Toda G., Gong J., Kufe D., Ohno T., Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice Journal of Gastroenterology 2001 36 11 764 771 (Pubitemid 33133502)
52. Zhang J. K., Li J., Zhang J., Chen H. B., Chen S. B., Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo World Journal of Gastroenterology 2003 9 3 479 484 (Pubitemid 36372111)
53. Iriei M., Homma S., Komita H., Zeniya M., Kufe D., Ohno T., Toda G., Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ mice International Journal of Cancer 2004 111 2 238 245 (Pubitemid 38924701)
54. Zhang H. M., Zhang L. W., Liu W. C., Cheng J., Si X. M., Ren J., Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma Cytotherapy 2006 8 6 580 588 (Pubitemid 44869859)
55. Sheng XI. L., Zhang H., In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells World Journal of Gastroenterology 2007 13 44 5944 5950 (Pubitemid 350148512)
56. mov J., Bubenk J., Bieblov J., Indrov M., Jandlov T., Immunotherapeutic efficacy of vaccines generated by fusion of dendritic cells and HPV16-associated tumour cells Folia Biologica 2005 51 1 19 24
57. Savai R., Schermuly R. T., Schneider M., Pullamsetti S. S., Grimminger F., Seeger W., Banat G. A., Hybrid-primed lymphocytes and hybrid vaccination prevent tumor growth of Lewis lung carcinoma in mice Journal of Immunotherapy 2006 29 2 175 187
58. Savai R., Schermuly R. T., Pullamsetti S. S., Schneider M., Greschus S., Ghofrani H. A., Traupe H., Grimminger F., Banat G. A., A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells Cancer Research 2007 67 11 5443 5453 (Pubitemid 46997285)
59. Ou X., Cai S., Liu P., Zeng J., He Y., Wu X., Du J., Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT Journal of Cancer Research and Clinical Oncology 2008 134 5 525 533 (Pubitemid 351422606)
60. Siders W. M., Vergilis K. L., Johnson C., Shields J., Kaplan J. M., Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells Molecular Therapy 2003 7 4 498 505 (Pubitemid 36553419)
61. Kjaergaard J., Shimizu K., Shu S., Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine Cellular Immunology 2003 225 2 65 74 (Pubitemid 38091551)
62. Matsue H., Matsue K., Edelbaum D., Walters M., Morita A., Takashima A., New strategy for efficient selection of dendritic cell-tumor hybrids and clonal heterogeneity of resulting hybrids Cancer Biology and Therapy 2004 3 11 1145 1151 (Pubitemid 41350998)
63. Kim G. Y., Chae H. J., Kim K. H., Yoon M. S., Lee K. S., Lee C. M., Moon D. O., Lee J. S., Jeong Y. I., Yung H. C., Park Y. M., Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo Bioscience, Biotechnology and Biochemistry 2007 71 1 215 221 (Pubitemid 46155165)
64. Yu Z., Ma B., Zhou Y., Zhang M., Long H., Wang Y., Fan Q., Allogeneic tumor vaccine produced by electrofusion between osteosarcoma cell line and dendritic cells in the induction of antitumor immunity Cancer Investigation 2007 25 7 535 541 (Pubitemid 350135732)
65. Zheng R., Cohen P. A., Paustian C. A., Johnson T. D., Lee W. T., Shu S., Koski G. K., Paired toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12 Cancer Research 2008 68 11 4045 4049
66. Yanai S., Adachi Y., Fuijisawa J. I., Jiang S., Okigaki M., Shi M., Shima C., Imai Y., Kwon A. H., Ikehara S., Anti-tumor effects of fusion cells of type 1 dendritic cells and Meth A tumor cells using hemagglutinating virus of Japan-envelope International Journal of Oncology 2009 35 2 249 255
67. Gong J., Koido S., Chen D., Tanaka Y., Huang L., Avigan D., Anderson K., Ohno T., Kufe D., Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12 Blood 2002 99 7 2512 2517 (Pubitemid 34525439)
68. Zhang W., Yang H., Zeng H., Enhancing antitumor by immunization with fusion of dendritic cells and engineered tumor cells Journal of Huazhong University of Science and Technology. Medical Science 2002 22 1 1 4 (Pubitemid 41559881)
69. Liu Y., Zhang W., Chan T., Saxena A., Xiang J., Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity Leukemia Research 2002 26 8 757 763 (Pubitemid 34628374)
70. Hao S., Bi X., Xu S., Wei Y., Wu X., Guo X., Carlsen S., Xiang J., Enhanced antitumor immunity derived from a novel vaccine of fusion hybrid between dendritic and engineered myeloma cells Experimental Oncology 2004 26 4 300 306
71. Xia D., Li F., Xiang J., Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity Cancer Biotherapy and Radiopharmaceuticals 2004 19 3 322 330 (Pubitemid 38924496)
72. Shi M., Su L., Hao S., Guo X., Xiang J., Fusion hybrid of dendritic cells and engineered tumor cells expressing interleukin-12 induces type 1 immune responses against tumor Tumori 2005 91 6 531 538 (Pubitemid 43251125)
73. Quant S., Sarde C. O., Gobert M. G., Kadouche J., Roseto A., Antitumor response against myeloma cells by immunization with mouse syngenic dendritoma Hybridoma 2005 24 4 182 188 (Pubitemid 41209173)
74. Alvarez E., Moga E., Barquinero J., Sierra J., Briones J., Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response Gene Therapy 2010 17 4 469 477
75. Lespagnard L., Mettens P., Verheyden A. M., Tasiaux N., Thielemans K., Van Meirvenne S., Geldhof A., De Baetselier P., Urbain J., Leo O., Moser M., Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity International Journal of Cancer 1998 76 2 250 258 (Pubitemid 28180380)
76. Wells J. W., Cowled C. J., Darling D., Guinn B. A., Farzaneh F., Noble A., Galea-Lauri J., Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity Cancer Immunology, Immunotherapy 2007 56 12 1861 1873 (Pubitemid 47512608)
77. Iinuma H., Okinaga K., Fukushima R., Inaba T., Iwasaki K., Okinaga A., Takahashi I., Kaneko M., Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma The Journal of Immunology 2006 176 6 3461 3469 (Pubitemid 43363993)
78. Draube A., Beyer M., Schumer S., Thomas R. K., Tresckow B. V., Koslowsky T. C., Krieglstein C. F., Schultze J. L., Wolf J., Efficient activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma Journal of Immunotherapy 2007 30 4 359 369 (Pubitemid 46684426)
79. Koido S., Hara E., Homma S., Torii A., Toyama Y., Kawahara H., Watanabe M., Yanaga K., Fujise K., Tajiri H., Gong J., Toda G., Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells Clinical Cancer Research 2005 11 21 7891 7900 (Pubitemid 41611636)
80. Koido S., Hara E., Torii A., Homma S., Toyama Y., Kawahara H., Ogawa M., Watanabe M., Yanaga K., Fujise K., Gong J., Toda G., Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells International Journal of Cancer 2005 117 4 587 595 (Pubitemid 41504546)
81. Hock B. D., Roberts G., McKenzie J. L., Gokhale P., Salm N., McLellan A. D., Patton N. W., Roake J. A., Exposure to the electrofusion process can increase the immunogenicity of human cells Cancer Immunology, Immunotherapy 2005 54 9 880 890 (Pubitemid 40991330)
82. Koido S., Hara E., Homma S., Torii A., Mitsunaga M., Yanagisawa S., Toyama Y., Kawahara H., Watanabe M., Yoshida S., Kobayashi S., Yanaga K., Fujise K., Tajiri H., Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells The Journal of Immunology 2007 178 1 613 622 (Pubitemid 46033645)
83. Koido S., Hara E., Homma S., Mitsunaga M., Takahara A., Nagasaki E., Kawahara H., Watanabe M., Toyama Y., Yanagisawa S., Kobayashi S., Yanaga K., Fujise K., Gong J., Tajiri H., Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells The Journal of Immunology 2007 179 7 4874 4883
84. Yang J. Y., Cao D. Y., Ma L. Y., Liu W. C., Dendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines Hepatology Research 2010 40 5 505 513
85. Imura K., Ueda Y., Hayashi T., Itoh T., Shimizu K., Tamai H., Yano Y., Naito K., Kohara J., Nakane K., Matsuura Y., Takeda A., Takeda T., Kawai K., Yamagishi H., Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique International Journal of Oncology 2006 29 3 531 539
86. Matsumoto S., Saito H., Tsujitani S., Ikeguchi M., Allogeneic gastric cancer cell-dendritic cell hybrids induce tumor antigen (carcinoembryonic antigen) specific CD8 + T cells Cancer Immunology, Immunotherapy 2006 55 2 131 139 (Pubitemid 41682585)
87. Koido S., Hara E., Homma S., Namiki Y., Komita H., Takahara A., Nagasaki E., Ito M., Sagawa Y., Mitsunaga M., Uchiyama K., Satoh K., Arihiro S., Ohkusa T., Gong J., Tajiri H., Dendritic/pancreatic carcinoma fusions for clinical use: comparative functional analysis of healthy-versus patient-derived fusions Clinical Immunology 2010 135 3 384 400
88. Gong J., Avigan D., Chen D., Wu Z., Koido S., Kashiwaba M., Kufe D., Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells Proceedings of the National Academy of Sciences of the United States of America 2000 97 6 2715 2718 (Pubitemid 30159237)
89. Zhang Y., Ma B., Zhou Y., Zhang M., Qiu X., Sui Y., Zhang X., Ma B., Fan Q., Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells Breast Cancer Research and Treatment 2007 105 3 277 286 (Pubitemid 47596446)
90. Serhal K., Baillou C., Ghinea N., Fontanges P., Dupuy F. P., Lemoine F. M., Lacave R., Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines International Journal of Oncology 2007 31 6 1357 1365
91. Koido S., Tanaka Y., Tajiri H., Gong J., Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells Vaccine 2007 25 14 2610 2619 (Pubitemid 46400930)
92. Vasir B., Wu Z., Crawford K., Rosenblatt J., Zarwan C., Bissonnette A., Kufe D., Avigan D., Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and Anti-CD3/CD28 promotes the expansion of activated tumor reactive cells The Journal of Immunology 2008 181 1 808 821
93. Rosenblatt J., Wu Z., Vasir B., Zarwan C., Stone R., Mills H., Friedman T., Konstantinopoulos P. A., Spentzos D., Ghebremichael M., Stevenson K., Neuberg D., Levine J. D., Joyce R., Tzachanis D., Boussiotis V., Kufe D., Avigan D., Generation of tumor-specific t lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28 Journal of Immunotherapy 2010 33 2 155 166
94. Weise J. B., Maune S., Grgh T., Kabelitz D., Arnold N., Pfisterer J., Hilpert F., Heiser A., A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC Auris Nasus Larynx 2004 31 2 149 153 (Pubitemid 38581170)
95. Gong J., Nikrui N., Chen D., Koido S., Wu Z., Tanaka Y., Cannistra S., Avigan D., Kufe D., Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity The Journal of Immunology 2000 165 3 1705 1711 (Pubitemid 30604610)
96. Koido S., Ohana M., Liu C., Nikrui N., Durfee J., Lerner A., Gong J., Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation Clinical Immunology 2004 113 3 261 269 (Pubitemid 39422605)
97. Koido S., Nikrui N., Ohana M., Xia J., Tanaka Y., Liu C., Durfee J. K., Lerner A., Gong J., Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use Gynecologic Oncology 2005 99 2 462 471 (Pubitemid 41502861)
98. Cheong S. C., Blangenois I., Franssen J. D., Servais C., Phan V., Trakatelli M., Bruyns C., Vile R., Velu T., Brandenburger A., Generation of cell hybrids via a fusogenic cell line Journal of Gene Medicine 2006 8 7 919 928 (Pubitemid 44097146)
99. Lundqvist A., Palmborg A., Bidla G., Whelan M., Pandha H., Pisa P., Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses Medical Oncology 2004 21 2 155 165 (Pubitemid 39108006)
100. Kim T. B., Park H. K., Chang J. H., Choi I. H., Kim K. H., Yoon S. J., Lee M. S., Jung H., Kim C. S., The establishment of dendritic cell-tumor fusion vaccines for hormone refractory prostate cancer cell Korean Journal of Urology 2010 51 2 139 144
101. Gottfried E., Krieg R., Eichelberg C., Andreesen R., Mackensen A., Krause S. W., Characterization of cells prepared by dendritic cell-tumor cell fusion Cancer Immunity 2002 5 1 11 (Pubitemid 38977471)
102. Hu Z., Liu S., Mai X., Hu Z., Liu C., Anti-tumor effects of fusion vaccine prepared by renal cell carcinoma 786-O cell line and peripheral blood dendritic cells of healthy volunteers in vitro and in human immune reconstituted SCID mice Cellular Immunology 2010 262 2 112 119
103. Koido S., Homma S., Hara E., Mitsunaga M., Namiki Y., Takahara A., Nagasaki E., Komita H., Sagawa Y., Ohkusa T., Fujise K., Gong J., Tajiri H., In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells Journal of Translational Medicine 2008 6, article 51
104. Cao D. Y., Yang J. Y., Yue S. Q., Tao K. S., Song Z. S., Wang D. S., Yang Y. L., Dou K. F., Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma Cellular Immunology 2009 259 1 13 20
105. Xu F., Ye Y. J., Liu W., Kong M., He Y., Wang S., Dendritic cell/tumor hybrids enhances therapeutic efficacy against colorectal cancer liver metastasis in SCID mice Scandinavian Journal of Gastroenterology 2010 45 6 707 713
106. Galea-Lauri J., Darling D., Mufti G., Harrison P., Farzaneh F., Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination Cancer Immunology, Immunotherapy 2002 51 6 299 310 (Pubitemid 34743982)
107. Kokhaei P., Rezvany M. R., Virving L., Choudhury A., Rabbani H., sterborg A., Mellstedt H., Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL Leukemia 2003 17 5 894 899 (Pubitemid 36626317)
108. Gong J., Koido S., Kato Y., Tanaka Y., Chen D., Jonas A., Galinsky I., Deangelo D., Avigan D., Kufe D., Stone R., Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts Leukemia Research 2004 28 12 1303 1312 (Pubitemid 39314410)
109. Banat G. A., Usluoglu N., Hoeck M., Ihlow K., Hoppmann S., Pralle H., Dendritic cells fused with core binding factor-beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes British Journal of Haematology 2004 126 4 593 601 (Pubitemid 39093103)
110. Allgeier T., Garhammer S., Nner E., Wahl U., Kronenberger K., Dreyling M., Hallek M., Mocikat R., Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia Cancer Letters 2007 245 1-2 275 283 (Pubitemid 44959357)
111. Lei Z., Zhang G. M., Hong M., Feng Z. H., Huang B., Fusion of dendritic cells and CD34+CD38- acute myeloid leukemia (AML) cells potentiates targeting AML-initiating cells by specific CTL induction Journal of Immunotherapy 2009 32 4 408 414
112. Raje N., Hideshima T., Davies F. E., Chauhan D., Treon S. P., Young G., Tai Y. T., Avigan D., Gong J., Schlossman R. L., Richardson P., Kufe D. W., Anderson K. C., Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma British Journal of Haematology 2004 125 3 343 352 (Pubitemid 38621765)
113. Vasir B., Borges V., Wu Z., Grosman D., Rosenblatt J., Irie M., Anderson K., Kufe D., Avigan D., Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation British Journal of Haematology 2005 129 5 687 700 (Pubitemid 40825831)
114. Yu Z., Ma B., Zhou Y., Zhang M., Qiu X., Fan Q., Activation of antitumor cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous osteosarcoma Experimental Oncology 2005 27 4 273 278 (Pubitemid 43139357)
115. Guo W., Guo Y., Tang S., Qu H., Zhao H., Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity Clinical Orthopaedics and Related Research 2008 466 9 2176 2183
116. Jantscheff P., Spagnoli G., Zajac P., Rochlitz C., Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells Cancer Immunology, Immunotherapy 2002 51 7 367 375 (Pubitemid 35002041)
117. Parkhurst M. R., DePan C., Riley J. P., Rosenberg S. A., Shu S., Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules The Journal of Immunology 2003 170 10 5317 5325 (Pubitemid 36554767)
118. Trevor K. T., Cover C., Ruiz Y. W., Akporiaye E. T., Hersh E. M., Landais D., Taylor R. R., King A. D., Walters R. E., Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application Cancer Immunology, Immunotherapy 2004 53 8 705 714 (Pubitemid 38962064)
119. Neves A. R., Ensina L. F.C., Anselmo L. B., Leite K. R.M., Buzaid A. C., Cmara-Lopes L. H., Barbuto J. A.M., Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed
120. Sloan A. E., Parajuli P., Human autologous dendritic cell-glioma fusions: feasibility and capacity to stimulate T cells with proliferative and cytolytic activity Journal of Neuro-Oncology 2003 64 1-2 177 183 (Pubitemid 36992472)
121. Sukhorukov V. L., Reuss R., Endter J. M., Fehrmann S., Katsen-Globa A., Gener P., Steinbach A., Mller K. J., Karpas A., Zimmermann U., Zimmermann H., A biophysical approach to the optimisation of dendritic-tumour cell electrofusion Biochemical and Biophysical Research Communications 2006 346 3 829 839
122. Aarntzen E. H. J. G., Figdor C. G., Adema G. J., Punt C. J. A., de Vries I. J. M., Dendritic cell vaccination and immune monitoring Cancer Immunology, Immunotherapy 2008 57 10 1559 1568
123. Puccetti P., Bianchi R., Fioretti M. C., Ayroldi E., Uyttenhove C., Van Pel A., Boon T., Grohmann U., Use of a skin test assay to determine tumor-specific CD8 + T cell reactivity European Journal of Immunology 1994 24 6 1446 1452 (Pubitemid 24169532)
124. Lesterhuis W. J., de Vries I. J. M., Schuurhuis D. H., Boullart A. C. I., Jacobs J. F. M., de Boer A. J., Scharenborg N. M., Brouwer H. M. H., van de Rakt M. W. M. M., Figdor C. G., Ruers T. J., Adema G. J., Punt C. J. A., Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests Annals of Oncology 2006 17 6 974 980 (Pubitemid 43778989)
125. Mrten A., Renoth S., Heinicke T., Albers P., Pauli A., Mey U., Caspari R., Flieger D., Hanfland P., Von Ruecker A., Eis-Hbinger A. M., Mller S., Schwaner I., Lohmann U., Heylmann G., Sauerbruch T., Schmidt-Wolf I. G. H., Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma Human Gene Therapy 2003 14 5 483 494 (Pubitemid 36403540)
126. Waanders G. A., Rimoldi D., Linard D., Carrel S., Lejeune F., Dietrich P. Y., Cerottini J. C., Romero P., Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line Clinical Cancer Research 1997 3 5 685 696 (Pubitemid 27244334)
127. de Vries I. J. M., Bernsen M. R., Lesterhuis W. J., Scharenborg N. M., Strijk S. P., Gerritsen M.-J. P., Ruiter D. J., Figdor C. G., Punt C. J.A., Adema G. J., Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome Journal of Clinical Oncology 2005 23 24 5779 5787
128. Therasse P., Arbuck S. G., Eisenhauer E. A., Wanders J., Kaplan R. S., Rubinstein L., Verweij J., Van Glabbeke M., Van Oosterom A. T., Christian M. C., Gwyther S. G., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada Journal of the National Cancer Institute 2000 92 3 205 216
129. Miller A. B., Hoogstraten B., Staquet M., Winkler A., Reporting results of cancer treatment Cancer 1981 47 1 207 214 (Pubitemid 11167383)
130. Morse M. A., Hall J. R., Plate J. M. D., Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer Expert Opinion on Biological Therapy 2009 9 3 331 339
131. Kormelink T. G., Abudukelimu A., Redegeld F. A., Mast cells as target in cancer therapy Current Pharmaceutical Design 2009 15 16 1868 1878
132. Fassnacht M., Lee J., Milazzo C., Boczkowski D., Su Z., Nair S., Gilboa E., Induction of CD4 + and CD8 + T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy Clinical Cancer Research 2005 11 15 5566 5571 (Pubitemid 41060834)
133. Hasbold J., Gett A. V., Rush J. S., Deenick E., Avery D., Jun J., Hodgkin P. D., Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester Immunology and Cell Biology 1999 77 6 516 522
134. Tanaka Y., Koido S., Xia J., Ohana M., Liu C., Cote G. M., Sawyer D. B., Calderwood S., Gong J., Development of antigen-specific CD8 + CTL in MHC class I-deficient mice through CD4 to CD8 conversion The Journal of Immunology 2004 172 12 7848 7858 (Pubitemid 38747653)
135. Avigan D., Vasir B., Gong J., Borges V., Wu Z., Uhl L., Atkins M., Mier J., McDermott D., Smith T., Giallambardo N., Stone C., Schadt K., Dolgoff J., Tetreault J. C., Villarroel M., Kufe D., Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses Clinical Cancer Research 2004 10 14 4699 4708 (Pubitemid 38955520)
136. Avigan D. E., Vasir B., George D. J., Oh W. K., Atkins M. B., McDermott D. F., Kantoff P. W., Figlin R. A., Vasconcelles M. J., Xu Y., Kufe D., Bukowski R. M., Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma Journal of Immunotherapy 2007 30 7 749 761 (Pubitemid 47480758)
137. Kikuchi T., Akasaki Y., Abe T., Fukuda T., Saotome H., Ryan J. L., Kufe D. W., Ohno T., Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12 Journal of Immunotherapy 2004 27 6 452 459 (Pubitemid 39447353)
138. Homma S., Kikuchi T., Ishiji N., Ochiai K., Takeyama H., Saotome H., Sagawa Y., Hara E., Kufe D., Ryan J. L., Ohno T., Toda G., Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12 European Journal of Clinical Investigation 2005 35 4 279 286 (Pubitemid 40546927)
139. Czerkinsky C., Andersson G., Ekre H. P., Nilsson L. A., Klareskog L., Ouchterlony O., Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secretion cells Journal of Immunological Methods 1988 110 1 29 36
140. Suni M. A., Picker L. J., Maino V. C., Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry Journal of Immunological Methods 1998 212 1 89 98 (Pubitemid 28288190)
141. Schmittel A., Keilholz U., Scheibenbogen C., Evaluation of the interferon- ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood Journal of Immunological Methods 1997 210 2 167 174 (Pubitemid 28266560)
142. Schmittel A., Keilholz U., Thiel E., Scheibenbogen C., Quantification of tumor-specific T lymphocytes with the ELISPOT assay Journal of Immunotherapy 2000 23 3 289 295 (Pubitemid 30327363)
143. Rosenblatt J., Vasir B., Uhl L., Blotta S., Macnamara C., Somaiya P., Wu Z., Joyce R., Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma Blood 2011 117 2 393 402
144. Scheibenbogen C., Schmittel A., Keilholz U., Allguer T., Hofmann U., Regina M., Thiel E., Schadendorf D., Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma Journal of Immunotherapy 2000 23 2 275 281 (Pubitemid 30165177)
145. Liu L., Chahroudi A., Silvestri G., Wernett M. E., Kaiser W. J., Safrit J. T., Komoriya A., Altman J. D., Packard B. Z., Feinberg M. B., Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates Nature Medicine 2002 8 2 185 189 (Pubitemid 34155131)
146. Jerome K. R., Sloan D. D., Aubert M., Measuring T-cell-mediated cytotoxicity using antibody to activated caspase 3 Nature Medicine 2003 9 1 4 5 (Pubitemid 36098242)
147. Goldberg J. E., Sherwood S. W., Clayberger C., A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry Journal of Immunological Methods 1999 224 1-2 1 9 (Pubitemid 29273974)
148. Homma S., Matai K., Irie M., Ohno T., Kufe D., Toda G., Immunotherapy using fusions of autologous dendritic cells and tumor cells showed effective clinical response in a patient with advanced gastric carcinoma Journal of Gastroenterology 2003 38 10 989 994 (Pubitemid 37455788)
149. Kikuchi T., Akasaki Y., Irie M., Homma S., Abe T., Ohno T., Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells Cancer Immunology, Immunotherapy 2001 50 7 337 344 (Pubitemid 32835343)
150. Trefzer U., Weingart G., Chen Y., Herberth G., Adrian K., Winter H., Audring H., Guo Y., Sterry W., Walden P., Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma International Journal of Cancer 2000 85 5 618 626 (Pubitemid 30080472)
151. Trefzer U., Herberth G., Wohlan K., Milling A., Thiemann M., Sharav T., Sparbier K., Sterry W., Walden P., Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results Vaccine 2005 23 17-18 2367 2373 (Pubitemid 40341486)
152. Krause S. W., Neumann C., Soruri A., Mayer S., Peters J. H., Andreesen R., The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells Journal of Immunotherapy 2002 25 5 421 428
153. Haenssle H. A., Krause S. W., Emmert S., Zutt M., Kretschmer L., Schmidberger H., Andreesen R., Soruri A., Hybrid cell vaccination in metastatic melanoma: clinical and immunologic results of a phase I/II study Journal of Immunotherapy 2004 27 2 147 155 (Pubitemid 38282734)
154. Zhou J., Weng D., Zhou F., Pan K., Song H., Wang Q., Wang H., Wang H., Li Y., Huang L., Zhang H., Huang W., Xia J., Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses Cancer Immunology, Immunotherapy 2009 58 10 1587 1597
155. Su H., Chang D. S., Gambhir S. S., Braun J., Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography The Journal of Immunology 2006 176 7 4459 4467 (Pubitemid 44264426)
156. Finn O. J., Molecular origins of cancer: cancer immunology The New England Journal of Medicine 2008 358 25 2704 2715 (Pubitemid 351860863)
157. Chattopadhyay P. K., Yu J., Roederer M., A live-cell assay to detect antigen-specific CD4 + T cells with diverse cytokine profiles Nature Medicine 2005 11 10 1113 1117 (Pubitemid 41486835)
158. Altman J. D., Moss P. A. H., Goulder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M., Phenotypic analysis of antigen-specific T lymphocytes Science 1996 274 5284 94 96 (Pubitemid 26332731)
159. Klebanoff C. A., Gattinoni L., Restifo N. P., CD8 + T-cell memory in tumor immunology and immunotherapy Immunological Reviews 2006 211 214 224 (Pubitemid 43882974)
160. Walker E. B., Haley D., Miller W., Floyd K., Wisner K. P., Sanjuan N., Maecker H., Romero P., Hu H. M., Alvord W. G., Smith J. W., Fox B. A., Urba W. J., gp100(209-2M) peptide immunization of human lymphocyte antigen-A2 + stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8 + T cells Clinical Cancer Research 2004 10 2 668 680 (Pubitemid 38174007)
161. Houtenbos I., Westers T. M., Dijkhuis A., de Gruijl T. D., Ossenkoppele G. J., van de Loosdrecht A. A., Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting Clinical Cancer Research 2007 13 1 307 315 (Pubitemid 46121884)
162. Kalams S. A., Johnson R. P., Trocha A. K., Dynan M. J., Ngo H. S., D'Aquila R. T., Kurnick J. T., Walker B. D., Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire Journal of Experimental Medicine 1994 179 4 1261 1271 (Pubitemid 24091785)
163. Ramsdell F., Fowlkes B. J., Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance Science 1990 248 4961 1342 1348
164. Law J. P., Hirschkorn D. F., Owen R. E., Biswas H. H., Norris P. J., Lanteri M. C., The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells Cytometry Part A 2009 75 12 1040 1050
165. Teicher B. A., Transforming growth factor- and the immune response to malignant disease Clinical Cancer Research 2007 13 21 6247 6251 (Pubitemid 350075011)
166. Fricke I., Mirza N., Dupont J., Lockhart C., Jackson A., Lee JI. H., Sosman J. A., Gabrilovich D. I., Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses Clinical Cancer Research 2007 13 16 4840 4848 (Pubitemid 47298146)
167. Elgert K. D., Alleva D. G., Mullins D. W., Tumor-induced immune dysfunction: the macrophage connection Journal of Leukocyte Biology 1998 64 3 275 290 (Pubitemid 28409233)
168. Houston A., Bennett M. W., O'Sullivan G. C., Shanahan F., O'Connell J., Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF- expression British Journal of Cancer 2003 89 7 1345 1351 (Pubitemid 37363427)
169. Takeda K., Kojima Y., Uno T., Hayakawa Y., Teng M. W.L., Yoshizawa H., Yagita H., Gejyo F., Okumura K., Smyth M. J., Combination therapy of established tumors by antibodies targeting immune activating and suppressing molecules The Journal of Immunology 2010 184 10 5493 5501
170. Uyttenhove C., Pilotte L., Thate I., Stroobant V., Colau D., Parmentier N., Boon T., Van den Eynde B. J., Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nature Medicine 2003 9 10 1269 1274 (Pubitemid 37279849)
171. Szajnik M., Czystowska M., Szczepanski M. J., Mandapathil M., Whiteside T. L., Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg) PLoS One 2010 5 7
172. Strauss L., Bergmann C., Szczepanski M., Gooding W., Johnson J. T., Whiteside T. L., A unique subset of CD4+CD25highFoxp3+T cells secreting interleukin-10 and transforming growth factor- 1 mediates suppression in the tumor microenvironment Clinical Cancer Research 2007 13 15 4345 4354 (Pubitemid 47219698)
173. Plebanski M., Katsara M., Sheng K. C., Xiang S. D., Apostolopoulos V., Methods to measure T-cell responses Expert Review of Vaccines 2010 9 6 595 600